Brighton, MA, United States of America

Maryann Giel-Moloney

This inventor holds 2 USPTO granted patents and 5 published patent applications. Top assignee: Sanofi Pasteur Biologics, LLC. Active years: 2014-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maryann Giel-Moloney. Retrieved from https://idiyas.com/inventor/maryann-giel-moloney

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.4

ph-index = 1


Company Filing History:


Years Active: 2014-2015

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Maryann Giel-Moloney: Innovator in Vaccine Development

Introduction

Maryann Giel-Moloney is a prominent inventor based in Brighton, MA (US). She has made significant contributions to the field of vaccine development, particularly in the area of flavivirus vaccines. With a total of 2 patents to her name, her work has the potential to impact public health positively.

Latest Patents

Maryann's latest patents focus on replication-defective flavivirus vaccines and vaccine vectors. These inventions provide innovative solutions for creating vaccines that are both effective and safe. The corresponding compositions and methods outlined in her patents represent a significant advancement in vaccine technology.

Career Highlights

Maryann Giel-Moloney is currently associated with Sanofi Pasteur Biologics, LLC, where she continues to work on groundbreaking vaccine research. Her expertise in the field has positioned her as a key player in the development of new vaccine strategies.

Collaborations

Throughout her career, Maryann has collaborated with notable professionals in the field, including Konstantin V Pugachev and Harold Kleanthous. These collaborations have further enhanced her research and contributed to the advancement of vaccine technology.

Conclusion

Maryann Giel-Moloney's contributions to vaccine development through her innovative patents and collaborations highlight her importance in the field. Her work continues to pave the way for advancements in public health and vaccine efficacy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…